2026 NPPES data Psychiatric/Mental Health Nurse Practitioner NPI 1295495588
Verify on CMS →

TEMITOPE AGUNBIADE

Psychiatric/Mental Health Nurse Practitioner in MONROE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 185 beneficiaries · Psychiatric/Mental Health Nurse Practitioner avg: 927
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$105.5
5 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TEMITOPE AGUNBIADE is a Psychiatric/Mental Health Nurse Practitioner ([object Object]) practicing in MONROE, New Jersey with a Medicare Part D prescribing footprint of 2K claims across 185 beneficiaries — 3% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $105.5 across 5 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TEMITOPE AGUNBIADE reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,559 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

TEMITOPE AGUNBIADE at a glance

Below national average

NPI registry status

Active

Issued 12/28/2021

NPI 1295495588

Primary specialty

Psychiatric/Mental Health Nurse Practitioner

Mid-sized

39,953 US NPIs in this specialty

Medicare Part D claims

1,559 68% vs specialty avg

2023 prescription claims

Specialty avg: 927

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Psychiatric/Mental Health Nurse Practitioner compares to other specialties among New Jersey providers

New Jersey providers

Psychiatric/Mental Health Nurse Practitioner share within New Jersey

1. Psychiatric/Mental Health Nurse Practitioner42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychiatric/Mental Health Nurse Practitioner share within New Jersey

Medicare quality performance — MIPS

TEMITOPE AGUNBIADE's 2023 MIPS final score plotted against the Psychiatric/Mental Health Nurse Practitioner national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Psychiatric/Mental Health Nurse Practitioner) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Psychiatric/Mental Health Nurse Practitioner) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TEMITOPE AGUNBIADE is a Psychiatric/Mental Health Nurse Practitioner provider practicing in MONROE, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1295495588. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TEMITOPE AGUNBIADE appears in the CMS NPPES registry as a Psychiatric/Mental Health Nurse Practitioner provider at 14 CRESTWOOD CT, MONROE, NJ, 08831, with a listed phone of (732) 586-7387. NPI 1295495588 was issued on 12/28/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AGUNBIADE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,559 prescription claims written by this provider, covering 185 Medicare beneficiaries and totaling roughly $46K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Psychiatric/Mental Health Nurse Practitioner is a mid-sized specialty nationwide, with 39,953 enrolled providers across 54 states and an average of 927 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

14 CRESTWOOD CT
MONROE, NJ 08831

Provider Details

NPI 1295495588
Specialty Psychiatric/Mental Health Nurse Practitioner
Gender Female
NPI Issued 12/28/2021

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where TEMITOPE AGUNBIADE bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BARNABAS HEALTH MEDICAL GROUP, PC
SOMERVILLE, NJ
NJ MEMORY AND BEHAVIORAL CARE
CEDAR KNOLLS, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TEMITOPE AGUNBIADE. Source: openpaymentsdata.cms.gov.

Total received

$106

Largest payer

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

TEMITOPE AGUNBIADE — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 1,559 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,559
Total Claims
$46K
Total Drug Cost
185
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,615
Total Day Supply
43,601
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$10K
Generic Drug Cost
$36K

Patient Demographics

Average Patient Age
81.0 years
Avg HCC Risk Score
2.34
Gender Split
79% female / 21% male
Age Distribution
<65: 14, 65-74: 34, 75-84: 56, 85+: 81

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Divalproex Sodium
193
Sertraline Hcl
169
Mirtazapine
142
Escitalopram Oxalate
110
Paroxetine Hcl
96
Risperidone
95
Quetiapine Fumarate
93
Alprazolam
81
Trazodone Hcl
81
Olanzapine
76

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatric/Mental Health Nurse Practitioner Overview

How TEMITOPE AGUNBIADE fits within the Psychiatric/Mental Health Nurse Practitioner landscape nationally.

39,953
Psychiatric/Mental Health Nurse Practitioner Providers in US
54
States with Psychiatric/Mental Health Nurse Practitioner
927
Avg Claims per Provider

TEMITOPE AGUNBIADE's 1,559 claims are above the specialty average of 927.

Nearby Psychiatric/Mental Health Nurse Practitioner Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as AGUNBIADE.

Compare Psychiatric/Mental Health Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is TEMITOPE AGUNBIADE's specialty?
TEMITOPE AGUNBIADE specializes in Psychiatric/Mental Health Nurse Practitioner and practices in MONROE, New Jersey.
How much does TEMITOPE AGUNBIADE prescribe under Medicare Part D?
In 2023, TEMITOPE AGUNBIADE wrote 1,559 Medicare Part D claims totaling $46K in drug costs for 185 beneficiaries.
What is TEMITOPE AGUNBIADE's Medicare quality score?
TEMITOPE AGUNBIADE has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TEMITOPE AGUNBIADE located?
TEMITOPE AGUNBIADE is located at 14 CRESTWOOD CT, MONROE, NJ, 08831. Phone: (732) 586-7387.
What is TEMITOPE AGUNBIADE's NPI number?
TEMITOPE AGUNBIADE's National Provider Identifier (NPI) is 1295495588, issued on 12/28/2021.
Does TEMITOPE AGUNBIADE prescribe more brand-name or generic drugs?
TEMITOPE AGUNBIADE's prescribing is 3% brand-name and 97% generic drugs by claim count, with $10K in brand drug costs.
How many Psychiatric/Mental Health Nurse Practitioner providers are there in the US?
There are 39,953 Psychiatric/Mental Health Nurse Practitioner providers across 54 states in the US. The average Psychiatric/Mental Health Nurse Practitioner provider writes 927 Medicare Part D claims per year.
What drugs does TEMITOPE AGUNBIADE prescribe most often?
Based on 2023 Medicare Part D data, TEMITOPE AGUNBIADE's most frequently prescribed drugs include Divalproex Sodium, Sertraline Hcl, Mirtazapine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TEMITOPE AGUNBIADE accept Medicare?
TEMITOPE AGUNBIADE appears in CMS Medicare data with 1,559 Part D claims and 185 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TEMITOPE AGUNBIADE's credentials?
TEMITOPE AGUNBIADE's NPI is 1295495588. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology